Minerva Neurosciences, Inc. Public Float
Minerva Neurosciences, Inc. (NERV) had Public Float of $7.00 million as of 2025-06-30, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-11
- 2025-06-30: Entity Public Float $7.00M.
- 2024-06-30: Entity Public Float $12.90M.
- 2024-06-28: Entity Public Float $12.90M.
- 2023-06-30: Entity Public Float $36.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $7.00M 10-K · filed 2026-03-11 |
| 2024-06-30 | $12.90M 10-K · filed 2025-02-25 |
| 2024-06-28 | $12.90M 10-K/A · filed 2025-04-29 |
| 2023-06-30 | $36.90M 10-K/A · filed 2024-04-22 |
| 2022-06-30 | $17.10M 10-K/A · filed 2023-04-20 |
| 2021-06-30 | $95.50M 10-K · filed 2022-03-01 |
| 2020-06-30 | $141.10M 10-K · filed 2021-03-08 |
| 2019-06-28 | $211.10M 10-K · filed 2020-03-09 |
| 2018-06-29 | $271.10M 10-K · filed 2019-03-12 |
| 2017-06-30 | $238.60M 10-K · filed 2018-03-12 |
| 2016-06-30 | $245.66M 10-K · filed 2017-03-13 |
| 2015-06-30 | $86.98M 10-K · filed 2016-03-14 |
| 2014-06-30 | $0.00 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |